Vesting condition for the incentive have been met. A well deserved reward for the Neuren employees if you ask me
from the annoucment dated 03/02/2022
Material terms:- Exercise price ($3.46 per share) is the volume weighted average price (VWAP) at which the Company's shares weretraded on the ASX in the 5 days preceding the date of issue of the Options.
- Vested options may be exercised no earlier than 1 year after the issue date.
- All options lapse 4 years after the issue date.
- Options are subject to the following vesting conditions:
(a) when the Company determines to progress NNZ-2591 to a Phase 2b or Phase 3 clinical trial following a positive Phase2 clinical trial outcome, or executes a partnering transaction for NNZ-2591;
(b) when the Company executes a partnering transaction for trofinetide outside North America, or submits a MarketingAuthorisation Application for trofinetide in the European Union, the United Kingdom or Japan.
(c) on acceptance by the US FDA of the filing of a New Drug Application for trofinetide.- The options carry no entitlement to vote or participate in new issues.
- Forums
- ASX - By Stock
- Ann: Application for quotation of securities - NEU
Vesting condition for the incentive have been met. A well...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.01 |
Change
-0.330(1.71%) |
Mkt cap ! $2.469B |
Open | High | Low | Value | Volume |
$19.60 | $19.65 | $19.01 | $1.037M | 53.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 419 | $19.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.06 | 339 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2008 | 19.070 |
2 | 428 | 19.060 |
2 | 217 | 19.050 |
4 | 268 | 19.040 |
2 | 205 | 19.030 |
Price($) | Vol. | No. |
---|---|---|
19.090 | 26 | 2 |
19.100 | 95 | 2 |
19.110 | 210 | 2 |
19.120 | 215 | 2 |
19.130 | 306 | 4 |
Last trade - 10.28am 06/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.27 |
  |
Change
-0.330 ( 0.15 %) |
|||
Open | High | Low | Volume | ||
$19.58 | $19.62 | $19.00 | 30237 | ||
Last updated 10.47am 06/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online